Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan-Reference-Cited by-同舟云学术

Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan

Published:2019-04-25 Issue: Volume: Page:
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Edahiro Yoko¹,Araki Marito²,Inano Tadaaki¹,Ito Masafumi³,Morishita Soji²,Misawa Kyohei¹^ORCID,Fukuda Yasutaka¹,Imai Misa¹,Ohsaka Akimichi²,Komatsu Norio¹^ORCID

Affiliation:

1. Department of Hematology Juntendo University Graduate School of Medicine Tokyo Japan

2. Department of Transfusion Medicine and Stem Cell Regulation Juntendo University Graduate School of Medicine Tokyo Japan

3. Department of Pathology Japanese Red Cross, Nagoya 1st Hospital Nagoya Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13236

Reference17 articles.

1. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification;Thiele J;Blood,2011

2. Essential thrombocythemia vs. early/prefibrotic myelofibrosis: why does it matter;Barosi G;Best Pract Res Clin Haematol,2014

3. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 IARC Lyon France SH Swerdlow E Campo NL Harris SH Swerdlow E Campo NL Harris ES Jaffe SA Pileri H Stein Primary myelofibrosis 44 47

4. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study;Barbui T;J Clin Oncol,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A lasso and random forest model using flow cytometry data identifies primary myelofibrosis;Cytometry Part B: Clinical Cytometry;2024-04-22

2. Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations;Pediatric Blood & Cancer;2023-06-19

3. Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan;American Journal of Clinical Pathology;2023-03-01

4. Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and Management;Laboratory Medicine;2022-08-12

5. Clinical features and next-generation sequencing landscape of essential thrombocythemia, prefibrotic primary myelofibrosis, and overt fibrotic primary myelofibrosis: a Chinese monocentric retrospective study;Journal of Cancer Research and Clinical Oncology;2022-06-22